BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details) - CAD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Disclosure of detailed information about biological assets [abstract] | ||
| Beginning Balance | $ 78 | $ 52 |
| Additions related to acquisitions of Trichome and MYM | 848 | |
| Production costs capitalized | 10,454 | 2,717 |
| Changes in fair value less cost to sell due to biological transformation | 7,210 | 11,782 |
| Transferred to inventory upon harvest | (16,977) | (14,478) |
| Foreign exchange translation | 74 | 5 |
| Ending Balance | $ 1,687 | $ 78 |
| X | ||||||||||
- Definition The increase in biological assets resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of living animals or plants recognised as assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The gains (losses) arising from changes in fair value less costs to sell of biological assets due to physical changes. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The increase (decrease) in biological assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of production costs capitalized on biological assets. No definition available.
|